Testosterone modulation of cardiac β-adrenergic signals in a rat model of heart failure

General and Comparative Endocrinology

Volumn 172, Issue 3, 2011, Pages 518-525

  Sun, Junfeng ^a   Fu, Lu ^a   Tang, Xianling ^a   Han, Ying ^a   Ma, Dan ^a   Cao, Junxian ^a   Kang, Ningning ^a   Ji, Hongfei ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Institute of Tumor Research   (China)

Author keywords

Apoptosis; G protein; Heart failure; Testosterone; Adrenoceptor

Indexed keywords

BETA ADRENERGIC RECEPTOR; DOXORUBICIN; ESTRADIOL; G PROTEIN COUPLED RECEPTOR KINASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN BCL 2; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CASTRATION; CONTROLLED STUDY; DOWN REGULATION; ECHOCARDIOGRAPHY; HEART CONTRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HORMONE RECEPTOR INTERACTION; HORMONE SUBSTITUTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SHAM PROCEDURE; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 79957804948     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2011.04.019     Document Type: Article

References (40)

1. Anand I.S., Ferrari R., Kalra G.S., Wahi P.L., Poole-Wilson P.A., Harris P.C. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 1989, 80:299-305.
2. Anker S.D., Chua T.P., Ponikowski P., Harrington D., Swan J.W., Kox W.J., Poole-Wilson P.A., Coats A.J. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997, 96:526-534.
3. Bisognano J.D., Weinberger H.D., Bohlmeyer T.J., Pende A., Raynolds M.V., Sastravaha A., Roden R., Asano K., Blaxall B.C., Wu S.C., Communal C., Singh K., Colucci W., Bristow M.R., Port D.J. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. J. Mol. Cell. Cardiol. 2000, 32:817-830.
4. Bohm M., Eschenhagen T., Gierschik P., Larisch K., Lensche H., Mende U., Schmitz W., Schnabel P., Scholz H., Steinfath M., et al. Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. J. Mol. Cell. Cardiol. 1994, 26:133-149.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
6. Brodde O.E., Bruck H., Leineweber K. Cardiac adrenoceptors: physiological and pathophysiological relevance. J. Pharmacol. Sci. 2006, 100:323-337.
7. Chesley A., Lundberg M.S., Asai T., Xiao R.P., Ohtani S., Lakatta E.G., Crow M.T. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ. Res. 2000, 87:1172-1179.
8. Communal C., Singh K., Sawyer D.B., Colucci W.S. Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 1999, 100:2210-2212.
9. Emorine L.J., Marullo S., Briend-Sutren M.M., Patey G., Tate K., Delavier-Klutchko C., Strosberg A.D. Molecular characterization of the human beta 3-adrenergic receptor. Science 1989, 245:1118-1121.
10. Engelhardt S., Hein L., Wiesmann F., Lohse M.J. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci. USA 1999, 96:7059-7064.
11. Eschenhagen T., Mende U., Nose M., Schmitz W., Scholz H., Haverich A., Hirt S., Doring V., Kalmar P., Hoppner W., et al. Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. Circ. Res. 1992, 70:688-696.
12. Golden K.L., Marsh J.D., Jiang Y. Castration reduces mRNA levels for calcium regulatory proteins in rat heart. Endocrine 2002, 19:339-344.
13. Golden K.L., Marsh J.D., Jiang Y. Testosterone regulates mRNA levels of calcium regulatory proteins in cardiac myocytes. Horm. Metab. Res. 2004, 36:197-202.
14. Golden K.L., Marsh J.D., Jiang Y., Brown T., Moulden J. Gonadectomy of adult male rats reduces contractility of isolated cardiac myocytes. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E449-E453.
15. Han Y., Fu L., Sun W., Cao J., Xie R., Zhou P., Kang N., Sun J. Neuroprotective effects of testosterone upon cardiac sympathetic function in rats with induced heart failure. Eur. J. Pharmacol. 2009, 619:68-74.
16. Holmer S.R., Stevens S., Homcy C.J. Tissue- and species-specific expression of inhibitory guanine nucleotide-binding proteins. Cloning of a full-length complementary DNA from canine heart. Circ. Res. 1989, 65:1136-1140.
17. Jankowska E.A., Biel B., Majda J., Szklarska A., Lopuszanska M., Medras M., Anker S.D., Banasiak W., Poole-Wilson P.A., Ponikowski P. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 2006, 114:1829-1837.
18. Kato K., Yin H., Agata J., Yoshida H., Chao L., Chao J. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1506-H1514.
19. Kiuchi K., Shannon R.P., Komamura K., Cohen D.J., Bianchi C., Homcy C.J., Vatner S.F., Vatner D.E. Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J. Clin. Invest. 1993, 91:907-914.
20. Kompa A.R., Gu X.H., Evans B.A., Summers R.J. Desensitization of cardiac beta-adrenoceptor signaling with heart failure produced by myocardial infarction in the rat. Evidence for the role of Gi but not Gs or phosphorylating proteins. J. Mol. Cell Cardiol. 1999, 31:1185-1201.
21. Kouchi I., Zolk O., Jockenhovel F., Itter G., Linz W., Cremers B., Bohm M. Increase in G(i alpha) protein accompanies progression of post-infarction remodeling in hypertensive cardiomyopathy. Hypertension 2000, 36:42-47.
22. Kumai T., Tanaka M., Tateishi T., Watanabe M., Nakura H., Asoh M., Kobayashi S. Effects of anti-androgen treatment on the catecholamine synthetic pathway in the adrenal medulla of spontaneously hypertensive rats. Naunyn. Schmiedebergs Arch. Pharmacol. 1998, 357:620-624.
23. Langin D., Tavernier G., Lafontan M. Regulation of beta 3-adrenoceptor expression in white fat cells. Fundam. Clin. Pharmacol. 1995, 9:97-106.
24. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 1990, 323:236-241.
25. Li Z.K., Zhu S.J., Yu L.J., Tian Y., Zhou Y.Z., Wang J. The relationship between expressions of beta1-, beta2-, beta3-adrenoceptor mRNA of myocardium and cardiac function in patients with heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 2005, 33:351-353.
26. Luetje C.W., Tietje K.M., Christian J.L., Nathanson N.M. Differential tissue expression and developmental regulation of guanine nucleotide binding regulatory proteins and their messenger RNAs in rat heart. J. Biol. Chem. 1988, 263:13357-13365.
27. Maddali K.K., Korzick D.H., Tharp D.L., Bowles D.K. PKCdelta mediates testosterone-induced increases in coronary smooth muscle Cav1.2. J. Biol. Chem. 2005, 280:43024-43029.
28. Malkin C.J., Jones T.H., Channer K.S. Testosterone in chronic heart failure. Front Horm Res. 2009, 37:183-196.
29. Molenaar P., Parsonage W.A. Fundamental considerations of beta-adrenoceptor subtypes in human heart failure. Trends Pharmacol. Sci. 2005, 26:368-375.
30. Moniotte S., Kobzik L., Feron O., Trochu J.N., Gauthier C., Balligand J.L. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 2001, 103:1649-1655.
31. Penna C., Abbadessa G., Mancardi D., Spaccamiglio A., Racca S., Pagliaro P. Nandrolone-pretreatment enhances cardiac beta(2)-adrenoceptor expression and reverses heart contractile down-regulation in the post-stress period of acute-stressed rats. J. Steroid Biochem. Mol. Biol. 2007, 107:106-113.
32. Rozec B., Gauthier C. Beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol. Ther. 2006, 111:652-673.
33. Scheuer J., Malhotra A., Schaible T.F., Capasso J. Effects of gonadectomy and hormonal replacement on rat hearts. Circ. Res. 1987, 61:12-19.
34. Suzuki K., Murtuza B., Suzuki N., Smolenski R.T., Yacoub M.H. Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure. Circulation 2001, 104:I213-I217.
35. Swan J.W., Walton C., Godsland I.F., Clark A.L., Coats A.J., Oliver M.F. Insulin resistance in chronic heart failure. Eur. Heart J. 1994, 15:1528-1532.
36. R.P. Xiao, Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Sci. STKE 2001 (2001) re15.
37. Xiao R.P., Zhu W., Zheng M., Chakir K., Bond R., Lakatta E.G., Cheng H. Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol. Sci. 2004, 25:358-365.
38. Zaugg M., Xu W., Lucchinetti E., Shafiq S.A., Jamali N.Z., Siddiqui M.A. Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 2000, 102:344-350.
39. Zhu W.Z., Wang S.Q., Chakir K., Yang D., Zhang T., Brown J.H., Devic E., Kobilka B.K., Cheng H., Xiao R.P. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J. Clin. Invest. 2003, 111:617-625.
40. Zhu W.Z., Zheng M., Koch W.J., Lefkowitz R.J., Kobilka B.K., Xiao R.P. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc. Natl. Acad. Sci. USA 2001, 98:1607-1612.